van Hoogstraten, L. M. et al. World traits within the epidemiology of bladder most cancers: challenges for public well being and scientific apply. Nat. Rev. Clin. Oncol. 20, 287–304 (2023).
Kim, J.-S., Lee, J., Nguyen, T. T. & Choi, S. Y. Optimum timing for the primary cystoscopic follow-up utilizing time-to-treatment initiation evaluation of oncologic outcomes in main non-muscle invasive bladder most cancers. Sci. Rep. 14, 8440 (2024).
Mossanen, M. & Gore, J. L. The burden of bladder most cancers care: direct and oblique prices. Curr. Opin. Urol. 24, 487–491 (2014).
Sievert, Okay. D. et al. Financial features of bladder most cancers: what are the advantages and prices? World J. Urol. 27, 295–300 (2009).
Tan, W. S., Rodney, S., Lamb, B., Feneley, M. & Kelly, J. Administration of non-muscle invasive bladder most cancers: a complete evaluation of pointers from the US, Europe and Asia. Most cancers Deal with. Rev. 47, 22–31 (2016).
Grabe-Heyne, Okay. et al. Intermediate and high-risk non-muscle-invasive bladder most cancers: an summary of epidemiology, burden, and unmet wants. Entrance. Oncol. 13, 1170124 (2023).
Holzbeierlein, J. M. et al. Prognosis and remedy of non-muscle invasive bladder most cancers: AUA/SUO guideline: 2024 modification. J. Urol. 211, 533–538 (2024).
Shkolyar, E. et al. Optimizing cystoscopy and TURBT: enhanced imaging and synthetic intelligence. Nat. Rev. Urol. 22, 46–54 (2025).
Maas, M., Todenhöfer, T. & Black, P. C. Urine biomarkers in bladder most cancers—present standing and future views. Nat. Rev. Urol. 20, 597–614 (2023).
Ng, Okay., Stenzl, A., Sharma, A. & Vasdev, N. Urinary biomarkers in bladder most cancers: A evaluate of the present panorama and future instructions. Urologic Oncology: Seminars and Authentic Investigations 39, 41–51 (2021).
Thomas, C. E., Sexton, W., Benson, Okay., Sutphen, R. & Koomen, J. Urine assortment and processing for protein biomarker discovery and quantification. Most cancers Epidemiol. Biomark. Prev. 19, 953–959 (2010).
Lee, S., Oh, J., Cho, M. & Kim, J. Okay. Fluorescence-based microendoscopic sensing system for minimally invasive in vivo bladder most cancers prognosis. Biosensors 12, 631 (2022).
Witjes, J. A. et al. Scientific and price effectiveness of hexaminolevulinate-guided blue-light cystoscopy: proof evaluate and up to date skilled suggestions. Eur. Urol. 66, 863–871 (2014).
Alchera, E. et al. Early prognosis of bladder most cancers by photoacoustic imaging of tumor-targeted gold nanorods. Photoacoustics 28, 100400 (2022).
Sim, Okay. C. & Sung, D. J. Function of magnetic resonance imaging in tumor staging and follow-up for bladder most cancers. Transl. Androl. Urol. 9, 2890 (2020).
Simó, C. et al. Urease-powered nanobots for radionuclide bladder most cancers remedy. Nat. Nanotechnol. 19, 554–564 (2024).
Hafeez, S. & Huddart, R. Advances in bladder most cancers imaging. BMC Med. 11, 1–10 (2013).
Kwong, G. A. et al. Artificial biomarkers: a twenty-first century path to early most cancers detection. Nat. Rev. Most cancers 21, 655–668 (2021).
Joice, G. A., Bivalacqua, T. J. & Kates, M. Optimizing pharmacokinetics of intravesical chemotherapy for bladder most cancers. Nat. Rev. Urol. 16, 599–612 (2019).
Sweeney, S. Okay., Luo, Y., O’Donnell, M. A. & Assouline, J. Nanotechnology and most cancers: enhancing real-time monitoring and staging of bladder most cancers with multimodal mesoporous silica nanoparticles. Most cancers Nanotechnol. 7, 1–18 (2016).
Wu, D. et al. Delicate electrochemical immunosensor for detection of nuclear matrix protein-22 primarily based on NH2-SAPO-34 supported Pd/Co nanoparticles. Sci. Rep. 6, 24551 (2016).
Liang, L.-G. et al. An built-in double-filtration microfluidic gadget for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder most cancers. Sci. Rep. 7, 1–10 (2017).
Peng, C. et al. A colorimetric immunosensor primarily based on self-linkable dual-nanozyme for ultrasensitive bladder most cancers prognosis and prognosis monitoring. Biosens. Bioelectron. 126, 581–589 (2019).
Tomiyama, E. et al. EphA2 on urinary extracellular vesicles as a novel biomarker for bladder most cancers prognosis and its impact on the invasiveness of bladder most cancers. Br. J. Most cancers 127, 1312–1323 (2022).
Feng, Y. et al. Iodide-enhanced perovskite nanozyme-based colorimetric platform for detection of urinary nuclear matrix protein 22. ACS Appl. Mater. Interfaces 15, 27742–27749 (2023).
Li, Q. et al. Choline phosphate-grafted nanozymes as common extracellular vesicle probes for bladder most cancers detection. ACS Nano 18, 16113–16125 (2024).
Tune, F.-X. et al. Current progress in nanomaterial-based biosensors and theranostic nanomedicine for bladder most cancers. Biosensors 13, 106 (2023).
Hao, L. et al. Microenvironment-triggered multimodal precision diagnostics. Nat. Mater. 20, 1440–1448 (2021).
Landry, M. P. et al. Single-molecule detection of protein efflux from microorganisms utilizing fluorescent single-walled carbon nanotube sensor arrays. Nat. Nanotechnol. 12, 368–377 (2017).
Zhang, Y., Li, M., Gao, X., Chen, Y. & Liu, T. Nanotechnology in most cancers prognosis: progress, challenges and alternatives. J. Hematol. Oncol. 12, 1–13 (2019).
Hao, L. et al. CRISPR-Cas-amplified urinary biomarkers for multiplexed and moveable most cancers diagnostics. Nat. Nanotechnol. 18, 798–807 (2023).
Kim, M. et al. Detection of ovarian most cancers by way of the spectral fingerprinting of quantum-defect-modified carbon nanotubes in serum by machine studying. Nat. Biomed. Eng. 6, 267–275 (2022).
Lukacz, E. S. et al. A wholesome bladder: a consensus assertion. Int. J. Clin. Pract. 65, 1026–1036 (2011).
Machado, M., Yim, W. & Strano, M. S. A sensor answer to the femtomolar downside in bladder most cancers. ACS Sens. 10, 6501–6511 (2025).
Erickson, H. P. Dimension and form of protein molecules on the nanometer degree decided by sedimentation, gel filtration, and electron microscopy. Biol. Proced. On-line 11, 32–51 (2009).
Zheng, Z., Wan, Q., Meixiong, G. & Du, Q. Cell cycle–regulated membrane binding of NuMA contributes to environment friendly anaphase chromosome separation. Mol. Biol. Cell 25, 606–619 (2014).
Kotak, S., Busso, C. & Gönczy, P. NuMA interacts with phosphoinositides and hyperlinks the mitotic spindle with the plasma membrane. EMBO J. 33, 1815–1830 (2014).
Wang, W., Ji, X., Kapur, A., Zhang, C. & Mattoussi, H. A multifunctional polymer combining the imidazole and zwitterion motifs as a biocompatible compact coating for quantum dots. JACS 137, 14158–14172 (2015).
Silmore, Okay. S., Gong, X., Strano, M. S. & Swan, J. W. Excessive-resolution nanoparticle sizing with most a posteriori nanoparticle monitoring evaluation. ACS Nano 13, 3940–3952 (2019).
Park, M. et al. Measuring the accessible floor space throughout the nanoparticle corona utilizing molecular probe adsorption. Nano Lett. 19, 7712–7724 (2019).
Sánchez-Velázquez, G. et al. Utilizing molecular probe adsorption to characterize the nanoparticle corona section and molecular recognition. Langmuir 41, 17602–17614 (2025).
Miyake, M. et al. Influencing elements on the NMP-22 urine assay: an experimental mannequin. BMC Urol. 12, 1–6 (2012).
Jamshidian, H., Kor, Okay. & Djalali, M. Urine focus of nuclear matrix protein 22 for prognosis of transitional cell carcinoma of bladder. Urol J. 5, 243–247 (2008).
Messing, E. M. et al. Impact of intravesical instillation of gemcitabine vs saline instantly following resection of suspected low-grade non-muscle-invasive bladder most cancers on tumor recurrence: SWOG S0337 randomized scientific trial. JAMA 319, 1880–1888 (2018).
Cho, S.-Y. et al. Mobile lensing and close to infrared fluorescent nanosensor arrays to allow chemical efflux cytometry. Nat. Commun. 12, 3079 (2021).
Wu, D. et al. Phenolic-enabled nanotechnology: versatile particle engineering for biomedicine. Chem. Soc. Rev. 50, 4432–4483 (2021).
Kitazaki, S., Tanaka, A. & Hayashi, N. Sterilization of slender tube interior floor utilizing discharge plasma, ozone, and UV mild irradiation. Vacuum 110, 217–220 (2014).
John, J. et al. The porcine mannequin for urological analysis and coaching: an endoscopic and CT-based examine. Uro 6, 7 (2026).
Jin, Z. et al. Modification of poly(maleic anhydride)-based polymers with H2N–R nucleophiles: addition or substitution response? Bioconjugate Chem. 30, 871–880 (2019).
Zhang, J. et al. Molecular recognition utilizing corona section complexes fabricated from artificial polymers adsorbed on carbon nanotubes. Nat. Nanotechnol. 8, 959–968 (2013).
Yim, W. et al. Polyphenol-stabilized coacervates for enzyme-triggered drug supply. Nat. Commun. 15, 7295 (2024).
Kilani, R. et al. Selective cytotoxicity of gemcitabine in bladder most cancers cell strains. Anti-Most cancers Medication 13, 557–566 (2002).